PTHS

$23.85

Post-MarketAs of Mar 17, 8:00 PM UTC

Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.

OverviewIntradayAnalysisPROIntelligencePROAsk AIPRO

Intraday

Custom Range:
to
No data available for this range. Intraday data may be limited by the exchange.

Recent News

MT Newswires
Jul 10, 2025

Sector Update: Health Care Stocks Rise Late Afternoon

Health care stocks advanced late Thursday afternoon, with the NYSE Health Care Index rising 0.9% and

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.